Living donor liver transplantation for patients immunized against human leukocyte antigen

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 20, Issue 3, 2013, Pages 279-285

  Shindoh, Junichi ^a   Sugawara, Yasuhiko ^a   Tamura, Sumihito ^a   Kaneko, Junichi ^a   Yamashiki, Noriyo ^b   Aoki, Taku ^a   Hasegawa, Kiyoshi ^a   Sakamoto, Yoshihiro ^a   Kokudo, Norihiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Human leukocyte antigen; Liver transplantation; Platelet; Thrombocytopenia; Transfusion

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN; HLA ANTIGEN CLASS 1 ANTIBODY; IMMUNOGLOBULIN; STEROID; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ALLOIMMUNIZATION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FEMALE; GRAFT RECIPIENT; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MEDICAL RECORD REVIEW; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; THROMBOCYTE DISORDER; THROMBOCYTE TRANSFUSION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; ANTIGENS, HUMAN PLATELET; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATAL OUTCOME; FEMALE; HLA ANTIGENS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PLATELET TRANSFUSION; POSTOPERATIVE COMPLICATIONS; THROMBOTIC MICROANGIOPATHIES; TREATMENT OUTCOME;

EID: 84879696777     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-012-0511-0     Document Type: Article

References (24)

1. Karuppan S, Ericzon BG, Moller E. Relevance of a positive crossmatch in liver transplantation. Transpl Int. 1991;4:18-25.
2. Katz SM, Kimball PM, Ozaki C, Monsour H, Clark J, Cavazos D, et al. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients. Transplantation. 1994;57:616-20.
3. Saidman SL, Duquesnoy RJ, Demetris AJ, McCauley J, Ramos H, Mazariegos G, et al. Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol. 2004;2:61-7.
4. Sugawara Y, Makuuchi M, Kaneko J, Kishi Y, Hata S, Kokudo N. Positive T lymphocytotoxic cross-match in living donor liver transplantation. Liver Transpl. 2003;9:1062-6.
5. Hod E, Schwartz J. Platelet transfusion refractoriness. Br J Haematol. 2008;142:348-60.
6. Sugawara Y, Makuuchi M. Technical advances in living-related liver transplantation. J Hepatobiliary Pancreat Surg. 1999;6:245-53.
7. Sugawara Y, Makuuchi M. Right lateral sector graft as a feasible option for partial liver transplantation. Liver Transpl. 2004;10:1156-7.
8. Sugawara Y, Makuuchi M. Advances in adult living donor liver transplantation: a review based on reports from the 10th anniversary of the adult-to-adult living donor liver transplantation meeting in Tokyo. Liver Transpl. 2004;10:715-20.
9. Sugawara Y, Makuuchi M, Akamatsu N, Kishi Y, Niiya T, Kaneko J, et al. Refinement of venous reconstruction using cryopreserved veins in right liver grafts. Liver Transpl. 2004;10:541-7.
10. Kokudo N, Sugawara Y, Imamura H, Sano K, Makuuchi M. Sling suspension of the liver in donor operation: a gradual tape-repositioning technique. Transplantation. 2003;76:803-7.
11. Kokudo N, Sugawara Y, Kaneko J, Imamura H, Sano K, Kokudo N. Reconstruction of isolated caudate portal vein in left liver graft. Liver Transpl. 2004;10:1163-5.
12. Sugawara Y, Makuuchi M, Kaneko J, Ohkubo T, Imamura H, Kawarasaki H. Correlation between optimal tacrolimus doses and the graft weight in living donor liver transplantation. Clin Transplant. 2002;16:102-6.
13. Shibata Y, Juju T, Nishizawa Y, Sakamoto H, Ozawa N. Detection of platelet antibodies by a newly developed mixed agglutination with platelets. Vox Sang. 1981;41:25-31.
14. Terasaki PI, McClelland JB. Microdroplet assay of human serum cytotoxins. Nature. 1964;204:998-1000.
15. Yankee RA, Graff KS, Dowling R, Henderson ES. Selection of unrelated compatible platelet donors by lymphocyte HL-A matching. N Engl J Med. 1973;288:760-4.
16. Narvios A, Reddy V, Martinez F, Lichtiger B. Slow infusion of platelets: a possible alternative in the management of refractory thrombocytopenic patients. Am J Hematol. 2005;79:80.
17. Kalmadi S, Tiu R, Lowe C, Jin T, Kalaycio M. Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage. Cancer. 2006;107:136-40.
18. Heuer L, Blumenberg D. Management of multi-transfused patient with positive HLA class I alloantibodies and thrombocytopenia associated with platelet dysfunction refractory to transfusion of cross-matched platelets. Blood Coagul Fibrinolysis. 2005;16:287-90.
19. Galan AM, Tonda R, Pino M, Reverter JC, Ordinas A, Escolar G. Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders. Transfusion. 2003;43:885-92.
20. Kickler T, Braine HG, Piantadosi S, Ness PM, Herman JH, Rothko K. A randomized, placebo-controlled trial of intravenous gammaglobulin in alloimmunized thrombocytopenic patients. Blood. 1990;75:313-6.
21. Moake J. Thrombotic microangiopathies: multimer, metalloprotease, and beyond. Clin Transl Sci. 2009;2:366-73.
22. Tanabe K, Tokumoto T, Ishida H, Shimmura H, Omoto K, Makiyama K, et al. Prospective analysis of thrombotic microangiopathy after renal transplantation: comparison between cyclosporine and tacrolimus immunosuppression. Transplant Proc. 2002;34:1819-20.
23. Miyata R, Shimazu M, Tababe M, Kawachi S, Hoshino K, Wakabayashi G, et al. Clinical characteristics of thrombotic microangiopathy following ABO incompatible living donor liver transplantation. Liver Transpl. 2007;13:1455-62.
24. Shindoh J, Sugawara Y, Akamatsu N, Kaneko J, Tamura S, Yamashiki N, et al. Thrombotic microangiopathy after living-donor liver transplantation. Am J Transplant. Epub 2011 Nov 9.